339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.

OBJECTIVES/GOALS: We assessed the relationship between C-peptide preservation and a serum exocrine pancreatic enzyme (trypsin) in a recently concluded clinical trial. We hypothesized that immunomodulatory treatment resulting in improved beta-cell function would be associated with improved trypsin le...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruggeman, Brittany S, McGrail, Kieran, Gonzalez, Nicole, Wasserfall, Clive, Campbell-Thompson, Martha, Atkinson, Mark, Haller, Michael, Schatz, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Valued Approaches
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209244/
http://dx.doi.org/10.1017/cts.2022.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209244/
http://dx.doi.org/10.1017/cts.2022.192

Ejemplares similares